Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
48.80
-1.93 (-3.80%)
Apr 27, 2026, 3:01 PM EDT - Market open
Moderna Market Cap
Moderna has a market cap or net worth of $19.35 billion as of April 27, 2026. Its market cap has increased by 87.69% in one year.
Market Cap
19.35B
Enterprise Value
12.72B
1-Year Change
87.69%
Ranking
Category
Stock Price
$48.80
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $19.35B, an increase of 216.31%. That is a compound annual growth rate of 16.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 20.12B | 74.60% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 33.36B |
| Royalty Pharma | 29.27B |
| Insmed | 29.18B |
| Revolution Medicines | 28.46B |
| BioNTech SE | 26.67B |
| Roivant Sciences | 19.62B |
| Incyte | 18.84B |
| Summit Therapeutics | 17.14B |